Impax Asset Management Group’s Integra LifeSciences IART Stock Holding History

Impax Asset Management Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,105	Closed	-$644K	–	322
2024 Q2	$644K	Buy	+22,105	New	+$656K	﹤0.01%	303
2020 Q3	–	Sell	-133,015	Closed	-$6.25M	–	280
2020 Q2	$6.25M	Buy	133,015 +18,015	+16%	+$886K	0.06%	137
2020 Q1	$5.14M	Buy	115,000 +25,000	+28%	+$1.31M	0.07%	145
2019 Q4	$5.25M	Buy	90,000 +35,000	+64%	+$2.08M	0.06%	158
2019 Q3	$3.3M	Buy	+55,000	New	+$3.28M	0.04%	175

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Impax Asset Management Group's IART Position: Q3 2024 in Review

Impax Asset Management Group sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 22,105 shares — an estimated $644K sold.

Impax Asset Management Group first reported a position in IART in Q3 2019 and held it in 5 quarters. The position peaked at $6.25M in Q2 2020. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

Impax Asset Management Group reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
Impax Asset Management Group sold 22,105 Integra LifeSciences shares in Q3 2024, an estimated $644K.
Impax Asset Management Group first reported a position in Integra LifeSciences in Q3 2019 and held it in 5 quarters.
Impax Asset Management Group's Integra LifeSciences position peaked at $6.25M in Q2 2020.
225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Impax Asset Management Group's 13F filing for Q3 2024, filed 30 Oct 2024.